Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron in Intracerebral Hemorrhage
NCT05369351Phase 2Recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Jan 2024
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mirabegron in intracerebral hemorrhage (ICH), sponsored by Tianjin Medical University General Hospital. Started Jan 2024; status: recruiting.
02
Drugs
mirabegron
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT05369351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05369351.